Investors might want to bet on Quest Diagnostics (DGX), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Personalis, Inc. is rated Buy, driven by strong momentum in its NeXT Personal Dx MRD test and recent Medicare coverage ...

Speeding up labs and cutting costs for patients is the goal of PeaceHealth's new outpatient lab service, according to the company.On April 29, PeaceHealth opene ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Gram‑negative bloodstream infections are associated with significant morbidity and mortality, making timely pathogen ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

ETHealthworld.com brings latest agilus diagnostics news, views and updates from all top sources for the Indian Health industry.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the Shield™ by Guardant blood-based screening test is now widely accessible for physician order through ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.86 per share, payable on July 22, 2026 ...

According to Mordor Intelligence, the esoteric testing market size was valued at USD 27.21 billion in 2025 and is projected to grow from USD 30.35 ...

According to Mordor Intelligence, the esoteric testing market size was valued at USD 27.21 billion in 2025 and is projected ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...